Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Amphotericin B Colloidal Dispersion in Healthy Chinese Subjects
NCT03577509Phase 1Completed
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Jul 2018
- Primary completion
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles
- Countries
- 1
01
Overview
Phase 1, open-label trial of amphotericin b cholesteryl sulfate complex in invasive fungal disease (IFD) (3 arms), sponsored by CSPC ZhongQi Pharmaceutical Technology. Primary endpoint: Pharmacokinetics of single infusion of ABCD at 672 hours. Started Jul 2018; status: completed.
02
Drugs
amphotericin b cholesteryl sulfate complex
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT03577509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03577509.